首页> 外文期刊>The Hastings Center report >The Right to Know: A Revised Standard for Reporting Incidental Findings A Revised Standard for Reporting Incidental Findings
【24h】

The Right to Know: A Revised Standard for Reporting Incidental Findings A Revised Standard for Reporting Incidental Findings

机译:知道的权利:报告附带调查结果的修订标准是报告附带调查结果的修订标准

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract During the course of biomedical research, researchers sometimes obtain information on participants that is outside the aim of the study but may nonetheless be relevant to the participants. These incidental findings, as they are known, have been the focus of a substantial amount of discussion in the bioethics literature, and a consensus has begun to emerge about what researchers should do in light of the possibility of incidental findings. A consensus, however, is not necessarily correct. In this article, we address the common view that reporting of incidental findings should be based primarily on the possibility of medical benefit, factoring in the findings’ validity, clinical actionability, and significance to health or reproduction. While such medical beneficence should not be discarded, the need to give proper attention to participants’ autonomy, privacy, and interests (especially considering discussion of participants’ right not to know) suggests an alternative standard for when to report incidental findings: even if they are of no direct medical benefit, incidental findings should be reported based on the extent to which the participant can be expected to comprehend the information. We will offer a preliminary defense of this alternative as best respecting participants’ autonomy and privacy and promoting their interests. However, we acknowledge that the standard would face significant practical barriers, and these barriers lead us to propose a metaconsent addendum that would allow subjects to essentially waive the comprehension standard when resource or other constraints make meeting it impracticable .
机译:摘要在生物医学研究过程中,研究人员有时获取关于在研究目的之外的参与者的信息,但可能与参与者有关。众所周知,这些附带的调查结果一直是生物伦理文学中大量讨论的重点,并开始符合研究人员应该根据偶然发现的可能性。然而,共识不一定是正确的。在本文中,我们解决了偶然调查结果的共同观,主要基于医疗利益的可能性,在调查结果,临床可行性和对健康或繁殖中的意义上进行分解。虽然不应丢弃这种医疗益性,但需要适当地关注参与者的自主权,隐私和利益(特别是考虑与参与者不知道的讨论)表明何时报告偶然调查结果的替代标准:即使他们没有直接的医疗福利,应根据参与者预期理解信息的程度报告偶然调查结果。我们将初步防御这一替代方案,以尊重参与者的自主和隐私,促进他们的利益。但是,我们承认,该标准将面临重大的实际障碍,这些障碍导致我们提出了一种允许受试者在资源或其他限制使其达到不切实际的情况下基本上放弃理解标准的代理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号